Search Results

Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial.

• Authors : Bergenstal, Richard M (AUTHOR); Weinstock, Ruth S (AUTHOR); Mathieu, Chantal (AUTHOR)

• Source: Lancet. Sep2024, Vol. 404 Issue 10458, p1132-1142. 11p.

Record details

The promise of once-weekly insulins for type 1 diabetes: update on progress.

• Authors : Love, Kaitlin M¹ (AUTHOR); Brown, Sue A^1,2 (AUTHOR)

• Source: Lancet. Sep2024, Vol. 404 Issue 10458, p1081-1083. 3p.

Record details

Agricola

Record details

Agricola

Record details

Agricola

Record details

Agricola

Record details

Agricola

Record details

Agricola

Record details

Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial.

• Authors : Russell-Jones, David (AUTHOR); Babazono, Tetsuya (AUTHOR); Cailleteau, Roman (AUTHOR)

Subjects: NOVO Nordisk A/S; TYPE 1 diabetes; INSULIN aspart

• Source: Lancet. Nov2023, Vol. 402 Issue 10413, p1636-1647. 12p.

Record details

Agricola

Record details